任天堂
医学
DLCO公司
特发性肺纤维化
内科学
肺活量
不利影响
单中心
扩散能力
肺
肺功能
作者
Deepak Talwar,Deepak Prajapat,Dhruv Talwar
出处
期刊:Lung India
[Medknow]
日期:2021-12-28
卷期号:39 (1): 27-33
被引量:3
标识
DOI:10.4103/lungindia.lungindia_393_21
摘要
Our results support the findings from previous studies, that nintedanib leads to annual decline in parameters such as FVC and DLCO and increased 6-MWD. It was found to be well tolerated in the Indian patients with IPF.
科研通智能强力驱动
Strongly Powered by AbleSci AI